Sunvozertinib
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for Sunvozertinib, covering 2024-03-25 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Study of Oral EGFR Inhibitor DZD6008 Combined With Sunvozertinib in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN8) [Phase 1, Phase 2]